Psychedelics
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
39
NCT02981173
Psilocybin for the Treatment of Cluster Headache
Phase: Phase 1
Role: Collaborator
Start: Dec 5, 2016
Completion: Oct 21, 2022
NCT03341689
Psilocybin for the Treatment of Migraine Headache
Start: Nov 1, 2017
Completion: Oct 31, 2021
Loading map...